Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
28%
Parkinson
13%
COVID-19 Immunity
12%
Clinical Data
8%
GBA1
8%
Interpretable Machine Learning
7%
Luxembourg
7%
Xanthine
6%
Metabolic Function
6%
Relevant Changes
6%
Device Therapy
6%
Self-stigma
6%
Disease Duration
6%
Secondary Data Analysis
6%
COVID-19 Pandemic Impact
6%
COVID-19 Related
6%
Fluid Intake
6%
Behavior Modification
6%
Comprehensive Approach
6%
Disease Effects
6%
People with Dementia
6%
Early Diagnosis
6%
Environmental Modification
6%
Long-read Sequencing
6%
Luxembourgish
6%
Priority Setting Partnership
6%
International Context
6%
Cardiovascular History
6%
Major Risk Factors
6%
Variant Severity
6%
Data Management
6%
COVID-19 Infection
6%
Cross-cohort
6%
Motor Fluctuations
6%
Authorship Criteria
6%
Metabolomics Data
6%
Outcome Prediction
6%
Gait Data
6%
Nursing Care
6%
Real-world Outcomes
6%
Staff Knowledge
6%
Mild Cognitive Impairment
6%
Clinical Decision Support Tool
6%
Pandemic Control Measures
6%
Social Determinants of Mental Health
6%
Levodopa-induced Dyskinesia
6%
Dopaminergic Pathway
6%
Risk Variant
6%
Prognostic Analysis
6%
Advanced PD
5%
Medicine and Dentistry
Parkinson's Disease
77%
Diseases
18%
Infection
12%
Gut Microbiome
12%
COVID-19
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Metabolomics
12%
Unified Parkinson's Disease Rating Scale
10%
Myelodysplastic Syndrome
10%
Comorbidity
9%
Progressive Supranuclear Palsy
9%
Prevalence
9%
Outpatient
7%
Atypical Parkinsonism
7%
Clinician
6%
Health Care
6%
Early Diagnosis
6%
Systematic Review
6%
Mild Cognitive Impairment
6%
microRNA
6%
Cardiovascular System
6%
Observational Study
6%
Physiotherapy
6%
Disease Duration
5%
Cohort Analysis
5%
Neuroscience
Parkinson's Disease
100%
Mild Cognitive Impairment
21%
Comorbidity
13%
L-DOPA
12%
Dyskinesia
12%
Progressive Supranuclear Palsy
9%
Atypical Parkinsonism
7%
Cognitive Disorders
7%
MicroRNA
6%
Memory Disorder
6%
